Filing Details
- Accession Number:
- 0001104659-11-023805
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-28 21:31:48
- Reporting Period:
- 2011-04-26
- Filing Date:
- 2011-04-28
- Accepted Time:
- 2011-04-28 21:31:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1061632 | S Roxanne Austin | 100 Abbott Park Road Abbott Park IL 60064 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares Without Par Value | Acquisiton | 2011-04-26 | 6,668 | $42.73 | 25,748 | No | 4 | M | Direct | |
Common Shares Without Par Value | Disposition | 2011-04-26 | 4,168 | $51.37 | 21,580 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2011-04-26 | 2,500 | $51.36 | 19,080 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Option (right to buy) | Disposition | 2011-04-26 | 6,668 | $0.00 | 6,668 | $42.73 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2001-04-27 | 2011-04-26 | No | 4 | M | Direct |
Footnotes
- Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.